Analyst Reco. WuXi Biologics (Cayman) Inc. OTC Markets

Stocks

WXXWY

US98260N1081

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 11:42:22 2026-06-17 am EDT			5-day change	1st Jan Change
7.560 ^USD	-0.66%		-0.79%	-5.50%

02:12am	CANbridge Pharmaceuticals Enters Service Agreements With WuXi Biologics, Baheal Medical	MT
Jun. 05	Wuxi Biologics Completes Topping Out of Drug Product Facility At Singapore Crdmo Hub	CI

Analyst Reco.

Nov. 28	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$37.36 From HK$34.23, Keeps at Buy	MT
25-07-16	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$34.23 From HK$34.36, Keeps at Buy	MT
25-03-31	Jefferies Adjusts WuXi Biologics (Cayman)'s Price Target to HK$45 From HK$35, Keeps at Buy	MT
25-03-26	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$34.36 From HK$30.59, Keeps at Buy	MT
25-02-20	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$30.59 From HK$19.30, Keeps at Buy	MT
25-02-04	UOB Kay Hian Upgrades Wuxi Biologics to Buy from Sell, Price Target is HK$23	MT
24-08-22	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$19.30 From HK$23.25, Keeps at Buy	MT
24-07-24	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$23.25 From HK$53.65, Keeps at Buy	MT
24-06-27	Bank of China Downgrades Wuxi Biologics (Cayman) to Hold From Buy, Price Target is HK$14	MT
24-03-01	Nomura Adjusts Wuxi Biologics' Price Target to HK$53.65 From HK$58.44, Keeps at Buy	MT
23-12-05	Nomura Adjusts Wuxi Biologics’ Price Target to HK$58.44 From HK$82.69, Keeps at Buy	MT
23-07-24	Nomura Adjusts Wuxi Biologics' Price Target to HK$82.69 From HK$86.68, Keeps at Buy	MT
23-06-21	Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$86.86 From HK$94.91, Keeps at Buy	MT
23-02-14	Nomura Adjusts WuXi Biologics' Price Target to HK$94.91 From HK$97.78, Keeps at Buy	MT
22-08-22	UBS Adjusts Wuxi Biologics’ Price Target to HK$113.12 From HK$110.67, Keeps at Buy	MT
22-08-05	Nomura Adjusts WuXi Biologics' Price Target to HK$97.78 From HK$95.75, Keeps at Buy	MT
22-06-08	UBS Adjusts Wuxi Biologics (Cayman)'s Price Target to HK$95.75 From HK$100.87, Keeps at Buy	MT
22-03-29	UBS Adjusts Wuxi Biologics' Price Target to HK$110.67 From HK$142, Keeps at Buy	MT
22-03-24	Nomura Adjusts WuXi Biologics' Price Target to HK$100.87 From HK$103.28, Keeps at Buy	MT
22-03-17	Nomura Adjusts WuXi Biologics' Price Target to HK$103.28 From HK$149.92, Keeps at Buy	MT
21-03-29	WUXI BIOLOGICS CAYMAN : Nomura Adjusts WuXi Biologics' Price Target to HK$116.8 From HK$213.1, Keeps at Buy	MT